Literature DB >> 28219116

Prevalence, timing of diagnosis and pregnancy outcome of abdominal wall defects after the introduction of a national prenatal screening program.

Hanneke Fleurke-Rozema1, Karline van de Kamp2, Marian Bakker1, Eva Pajkrt2, Caterina Bilardo1, Rosalinde Snijders1.   

Abstract

OBJECTIVE: To examine prevalence, time of diagnosis and outcome of fetuses with an exomphalos or gastroschisis, diagnosed since the introduction of a national prenatal screening program in 2007.
METHODS: A prospective cohort study was undertaken in two fetal medicine units in the Netherlands. Cases were included if the estimated due date was between 2009 and 2013. Outcome measures were gestational age at diagnosis, presence of additional anomalies and pregnancy outcome.
RESULTS: A total of 141 exomphalos and 44 gastroschisis cases were included in the study, of which, respectively, 96 and 95% were diagnosed prenatally. The majority of the cases are visualized prior to the 20-week scan. In the exomphalos group, 83% had additional anomalies of which 57% had a chromosomal anomaly. Additional anomalies were present in 11% of the gastroschisis cases of which 40% had a chromosomal anomaly. The pregnancy termination rate was 61% (exomphalos) and 14% (gastroschisis).
CONCLUSION: Almost all exomphalos and gastroschisis cases are diagnosed prenatally, the majority in the first trimester. Associated anomalies are far more common in exomphalos with a fourfold lower survival rate than gastroschisis. In the exomphalos group, the pregnancy termination rate doubled, while in the gastroschisis group the rate remained low.
© 2017 John Wiley & Sons, Ltd. © 2017 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 28219116     DOI: 10.1002/pd.5023

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  8 in total

1.  Adaptive Leadership in Parents Caring for their Children Born with Life-Threatening Conditions.

Authors:  Anne C McKechnie; Kathy A Johnson; Maureen J Baker; Sharron L Docherty; Steven R Leuthner; Suzanne Thoyre
Journal:  J Pediatr Nurs       Date:  2020-05-18       Impact factor: 2.145

Review 2.  Abdominal wall defects.

Authors:  Christina M Bence; Amy J Wagner
Journal:  Transl Pediatr       Date:  2021-05

3.  The validity of the viscero-abdominal disproportion ratio for type of surgical closure in all fetuses with an omphalocele.

Authors:  Nina C J Peters; Annelieke Hijkoop; Rosan L Lechner; Alex J Eggink; Joost van Rosmalen; Dick Tibboel; René M H Wijnen; Hanneke IJsselstijn; Titia E Cohen-Overbeek
Journal:  Prenat Diagn       Date:  2019-08-29       Impact factor: 3.050

4.  Omphalocele: national current birth prevalence and survival.

Authors:  Anna Fogelström; Cecilia Caldeman; Jenny Oddsberg; Anna Löf Granström; Carmen Mesas Burgos
Journal:  Pediatr Surg Int       Date:  2021-08-15       Impact factor: 1.827

5.  Current Challenges in the Treatment of the Omphalocele-Experience of a Tertiary Center from Romania.

Authors:  Elena Ţarcă; Elena Cojocaru; Laura Mihaela Trandafir; Alina Costina Luca; Răzvan Călin Tiutiucă; Lăcrămioara Ionela Butnariu; Claudia Florida Costea; Iulian Radu; Mihaela Moscalu; Viorel Ţarcă
Journal:  J Clin Med       Date:  2022-09-27       Impact factor: 4.964

6.  Complexity of gastroschisis predicts outcome: epidemiology and experience in an Australian tertiary centre.

Authors:  Sarah J Melov; Irene Tsang; Ralph Cohen; Nadia Badawi; Karen Walker; Soundappan S V Soundappan; Thushari I Alahakoon
Journal:  BMC Pregnancy Childbirth       Date:  2018-06-11       Impact factor: 3.007

Review 7.  Major abdominal wall defects in the low- and middle-income setting: current status and priorities.

Authors:  Lofty-John Chukwuemeka Anyanwu; Niyi Ade-Ajayi; Udo Rolle
Journal:  Pediatr Surg Int       Date:  2020-03-21       Impact factor: 1.827

8.  Decentralized surgery of abdominal wall defects in Germany.

Authors:  Andrea Schmedding; Boris Wittekind; Emilia Salzmann-Manrique; Rolf Schloesser; Udo Rolle
Journal:  Pediatr Surg Int       Date:  2020-03-26       Impact factor: 1.827

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.